## Distinguishing Atropine from Scopolamine ### Blood-Brain Barrier Penetration **Key Point:** The critical difference between atropine and scopolamine lies in their lipophilicity and CNS penetration, which determines their central effects. **High-Yield:** - **Atropine**: Quaternary ammonium compound (more polar) → **poor BBB penetration** → minimal CNS effects at therapeutic doses → causes **CNS excitation** (paradoxically, at very high doses) - **Scopolamine**: Tertiary amine (more lipophilic) → **readily crosses BBB** → significant CNS effects → causes **CNS depression** (sedation, amnesia, confusion) ### Comparative Table | Feature | Atropine | Scopolamine | | --- | --- | --- | | Chemical structure | Quaternary ammonium | Tertiary amine | | BBB penetration | Poor | Excellent | | CNS effect | Minimal (excitation at toxic doses) | Prominent depression (sedation) | | Duration | 4–6 hours | 3–7 days | | Mydriasis | Yes | Yes | | Miosis | No | No | | Clinical use | Anticholinergic toxidrome, premedication | Motion sickness, premedication | ### Clinical Pearl **Scopolamine's sedative property** makes it useful as a premedication and for motion sickness, whereas **atropine's lack of CNS effects** makes it safer for systemic anticholinergic therapy (e.g., organophosphate poisoning). ### Mnemonic **SCOPE** = **S**copolamine **C**rosses **O**ver the **P**lood-brain barri**E**r → causes CNS depression. [cite:KD Tripathi 8e Ch 6]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.